Advancements in Clinical Trials and Therapeutic Innovations in Healthcare Companies
Update: 2025-11-03
Description
Heidelberg Pharma AG is set to present new clinical data on their lead ADC candidate HDP-101, while the American Heart Association launches an initiative to enhance diagnosis and treatment of aortic stenosis. NanoViricides, Inc. is focusing on antiviral drug development, and Sapu Nano begins a clinical trial for Sapu-003. Soligenix Inc. strengthens its Advisory Leadership in Cutaneous T-Cell Lymphoma, and LogicMark innovates personal emergency response systems for at-risk populations.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
